$54.83
+2.41 (+4.60%)
Performance
1D
—
1W
—
1M
—
3M
+10.32%
6M
+0.46%
1Y
+53.93%
YTD
+1.97%
Open$53.05
Previous Close$52.42
Day High$55.85
Day Low$52.55
52W High$78.48
52W Low$33.50
Volume—
Avg Volume2.11M
Market Cap5.29B
P/E Ratio—
EPS$-6.51
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$54.19
Above
SMA 200
$54.12
Above
RSI (14)
52.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
35 analysts
Price Target
+102.6% upside
Current
$54.83
$54.83
Target
$111.08
$111.08
$83.97
$111.08 avg
$162.31
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.76M | 2.63M | 1.10B |
| Net Income | -623,792,175 | -392,569,021 | -133,819,624 |
| Profit Margin | -16,569.8% | -15,741.3% | -12.2% |
| EBITDA | -599,004,837 | -397,912,450 | -179,167,841 |
| Free Cash Flow | — | — | -115,939,335 |
| Rev Growth | +43.0% | +43.0% | +24.0% |
| Debt/Equity | — | — | 0.61 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |